Tiverton Asset Management’s Health Catalyst HCAT Stock Holding History

Tiverton Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.18M	Buy	+100,444	New	+$3.95M	0.11%	160

Other funds holding HCAT

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Tiverton Asset Management's HCAT Position: Q3 2019 in Review

Tiverton Asset Management opened a new position in Health Catalyst (HCAT) in Q3 2019: 100,444 shares worth $3.18M. The stake represents 0.11% of the portfolio and ranks #160 among its holdings.

86 funds tracked by Wall St. Rank hold HCAT as of Q3 2019.

Tiverton Asset Management held 100,444 shares of Health Catalyst worth $3.18M as of Q3 2019.
Health Catalyst was a new Tiverton Asset Management position in Q3 2019.
Health Catalyst made up 0.11% of Tiverton Asset Management's portfolio in Q3 2019, its #160 holding.
86 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.